Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK. · 2015
Read Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. by Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4480724.txt.
Description
Feng Wang and eight co-authors traced a regulatory chain that drives liver cancer growth in Oncotarget in 2015. A long non-coding RNA called UCA1 is abnormally active in several cancers. In hepatocellular carcinoma, the main liver cancer, its role was unclear. The team measured UCA1 in tumor tissue and tested its effects in liver cancer cells and in mice.
UCA1 ran high in tumors, and high levels tracked with advanced stage, spread, and shorter survival after surgery. Removing UCA1 slowed cancer cell growth and spread in dishes and in animals. UCA1 works as a sponge for a small RNA, miR-216b, freeing that RNA's target, a growth receptor called FGFR1, which in turn switches on the ERK signaling pathway. Blocking any link in the chain weakened the cancer cells. The network offers several points where a future drug might intervene.
Catalog record
| CREATOR | Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |